Insider · CIK 0001220036

GIBSON NEIL

Reports to the SEC for 1 company · MELVILLE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001220036

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2006-07-14	OSI PHARMACEUTICALS INCA Award	VP & Chief Scientific Officer	AAward	+5,000 sh	—	—	8,604
2006-06-13	OSI PHARMACEUTICALS INCStock Option (Right to Buy)A Award	VP & Chief Scientific Officer	AAward	+15K sh	—	—	15,000
2004-12-01	OSI PHARMACEUTICALS INCM Exercise/Conversion	VP & Chief Scientific Officer	MExercise/Conversion	+4,500 sh	$21.55	+$97K	6,155
2004-12-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−2,875 sh	$48.30	−$139K	3,280
2004-12-01	OSI PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	VP & Chief Scientific Officer	MExercise/Conversion	−4,500 sh	—	—	3,334
2004-11-19	OSI PHARMACEUTICALS INCA Award	VP & Chief Scientific Officer	AAward	+10 sh	$58.16	+$581.6	1,655
2004-09-13	OSI PHARMACEUTICALS INCM Exercise/Conversion	VP & Chief Scientific Officer	MExercise/Conversion	+2,000 sh	$30.74	+$61.5K	3,590
2004-09-13	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−1,175 sh	$63.00	−$74K	2,415
2004-09-13	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−300 sh	$63.02	−$18.9K	2,115
2004-09-13	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−200 sh	$63.03	−$12.6K	1,915
2004-09-13	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−200 sh	$63.05	−$12.6K	1,715
2004-09-13	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−125 sh	$63.07	−$7,883.75	1,590
2004-09-13	OSI PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	VP & Chief Scientific Officer	MExercise/Conversion	−2,000 sh	—	—	17,200
2004-06-17	OSI PHARMACEUTICALS INCStock Option (Right to Buy)A Award	VP & Chief Scientific Officer	AAward	+14.8K sh	—	—	14,800
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−11 sh	$38.18	−$419.98	5,489
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−203 sh	$38.20	−$7,754.6	5,286
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−85 sh	$38.23	−$3,249.55	5,201
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−1,671 sh	$38.24	−$63.9K	3,530
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−304 sh	$38.25	−$11.6K	3,226
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−1,282 sh	$38.30	−$49.1K	1,944
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−186 sh	$38.33	−$7,129.38	1,758
2004-04-01	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−168 sh	$38.34	−$6,441.12	1,590
2004-01-02	OSI PHARMACEUTICALS INCM Exercise/Conversion	VP & Chief Scientific Officer	MExercise/Conversion	+6,000 sh	$15.49	+$92.9K	6,000
2004-01-02	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−700 sh	$32.00	−$22.4K	5,300
2004-01-02	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−600 sh	$32.04	−$19.2K	4,700
2004-01-02	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−700 sh	$32.20	−$22.5K	4,000
2004-01-02	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−1,800 sh	$32.00	−$57.6K	2,200
2004-01-02	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−1,500 sh	$32.00	−$48K	700
2004-01-02	OSI PHARMACEUTICALS INCS Sale	VP & Chief Scientific Officer	SSale	−700 sh	$32.20	−$22.5K	0
2004-01-02	OSI PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	VP & Chief Scientific Officer	MExercise/Conversion	−6,000 sh	—	—	9,000

Recent filings

Accepted (ET)
Jul 184
OSI PHARMACEUTICALS INC0001127602-06-001812
SEC(opens sec.gov)
Jun 154
GIBSON NEIL0001127602-06-001520
SEC(opens sec.gov)
Dec 34
OSI PHARMACEUTICALS INC0001209191-04-055895
SEC(opens sec.gov)
Sep 144
GIBSON NEIL0001209191-04-044396
SEC(opens sec.gov)
Jun 214
GIBSON NEIL0001209191-04-032042
SEC(opens sec.gov)
Apr 64/A
GIBSON NEIL0001209191-04-019769
SEC(opens sec.gov)

Companies

OSI PHARMACEUTICALS INCVP & Chief Scientific Officer

Address

C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD

MELVILLE, NY, 11747